Human papillomavirus (HPV) continues to pose a significant threat to women’s health worldwide due to its link to cervical cancer. Globally, HPV is responsible for nearly all cases of cervical cancer, with over 300,000 deaths annually attributed to HPV-related cancers. Recent lab-based research has led to new diagnostic technologies, innovative approaches in vaccine development. These advancements have provided deeper insights into the HPV lifecycle and its interactions with the cervical and vaginal microbiome, and the prevalence of HPV infections. Understanding HPV prevalence is also crucial for identifying public health needs and guiding effective interventions.
To translate these scientific advancements into tangible health benefits, it is essential to focus on implementation science — the study of methods and strategies for translating research findings into effective and equitable healthcare practices. This Research Topic aims to explore how advancements in HPV research can be effectively implemented to improve HPV prevention, screening, and management.
We seek contributions that address the following themes:
• HPV Prevalence Studies: Analysing population-specific prevalence data to identify high-risk populations and inform intervention strategies.
• Innovations in HPV Diagnostics: Exploring new lab-based diagnostic technologies, including biomarkers for HPV. These biomarkers have potential applications in screening, triaging, and monitoring HPV-associated disease pathogenesis and treatment.
• Advancements in HPV Vaccination: Assessing novel vaccine formulations and tailored strategies for improving vaccination coverage and efficacy.
• Implementation science in HPV vaccination: Promoting deeper understanding of barriers to HPV vaccination including hesitancy using theory-informed frameworks and practical innovative strategies for enhancing demand and uptake of HPV vaccine at health facility- and community-level.
• Evaluating Impact: Measuring the effectiveness of new HPV interventions and their impact on women’s health outcomes.
• Policy directions: Updates on global, regional and national policies relevant to HPV prevention and control.
We welcome original research articles, reviews, and opinion pieces that contribute to a deeper understanding of HPV advancements and their implementation in healthcare systems. Interdisciplinary approaches and studies conducted in diverse settings are encouraged.
Through focused efforts in implementation science, this Research Topic aims to bridge the gap between lab-based discoveries and practical health solutions, advancing HPV interventions and improving outcomes for women globally.
Keywords:
HPV, Women's Health, Human papillomavirus (HPV), Cervical cancer, Vaccination, Implementation science, Diagnostics
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
Human papillomavirus (HPV) continues to pose a significant threat to women’s health worldwide due to its link to cervical cancer. Globally, HPV is responsible for nearly all cases of cervical cancer, with over 300,000 deaths annually attributed to HPV-related cancers. Recent lab-based research has led to new diagnostic technologies, innovative approaches in vaccine development. These advancements have provided deeper insights into the HPV lifecycle and its interactions with the cervical and vaginal microbiome, and the prevalence of HPV infections. Understanding HPV prevalence is also crucial for identifying public health needs and guiding effective interventions.
To translate these scientific advancements into tangible health benefits, it is essential to focus on implementation science — the study of methods and strategies for translating research findings into effective and equitable healthcare practices. This Research Topic aims to explore how advancements in HPV research can be effectively implemented to improve HPV prevention, screening, and management.
We seek contributions that address the following themes:
• HPV Prevalence Studies: Analysing population-specific prevalence data to identify high-risk populations and inform intervention strategies.
• Innovations in HPV Diagnostics: Exploring new lab-based diagnostic technologies, including biomarkers for HPV. These biomarkers have potential applications in screening, triaging, and monitoring HPV-associated disease pathogenesis and treatment.
• Advancements in HPV Vaccination: Assessing novel vaccine formulations and tailored strategies for improving vaccination coverage and efficacy.
• Implementation science in HPV vaccination: Promoting deeper understanding of barriers to HPV vaccination including hesitancy using theory-informed frameworks and practical innovative strategies for enhancing demand and uptake of HPV vaccine at health facility- and community-level.
• Evaluating Impact: Measuring the effectiveness of new HPV interventions and their impact on women’s health outcomes.
• Policy directions: Updates on global, regional and national policies relevant to HPV prevention and control.
We welcome original research articles, reviews, and opinion pieces that contribute to a deeper understanding of HPV advancements and their implementation in healthcare systems. Interdisciplinary approaches and studies conducted in diverse settings are encouraged.
Through focused efforts in implementation science, this Research Topic aims to bridge the gap between lab-based discoveries and practical health solutions, advancing HPV interventions and improving outcomes for women globally.
Keywords:
HPV, Women's Health, Human papillomavirus (HPV), Cervical cancer, Vaccination, Implementation science, Diagnostics
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.